港股異動 | 華潤醫療(1515.HK)漲超3% 與京煤集團簽訂重組協議
格隆匯6月29日丨華潤醫療(1515.HK)現報4.47港元,漲3.47%,暫成交3097萬港元,最新總市值58億港元。華潤醫療昨晚公佈,6月28日,公司下屬全資子公司華潤醫院控股與京煤集團簽訂了重組協議,正式落實訂約方於京煤集團下屬醫療機構開展合資共建的股權架構及合作模式。旨在充分發揮各自的優勢並共同對目標醫院集團實行改革和重組。目標醫院集團目前年收入達14.5億元,已成為門頭溝區的龍頭醫院,也是京西地區的核心醫療機構之一,資源價值稀缺。通過此次改革,有助於集團在北京市內獲取稀缺戰略資源。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.